Overall, the UALCAN graph underscores the tumor-specific upregulation of both IGSF11 and VISTA across a range of cancer types compared to normal counterparts (Table 2), reinforcing their relevance as potential targets in immune checkpoint blockade strategies. This evidence concerns the gene VSIR and neoplasm.